- News Home
17 April 2014 12:48 pm ,
Vol. 344 ,
Officials last week revealed that the U.S. contribution to ITER could cost $3.9 billion by 2034—roughly four times the...
An experimental hepatitis B drug that looked safe in animal trials tragically killed five of 15 patients in 1993. Now,...
Using the two high-quality genomes that exist for Neandertals and Denisovans, researchers find clues to gene activity...
A new report from the Intergovernmental Panel on Climate Change (IPCC) concludes that humanity has done little to slow...
Astronomers have discovered an Earth-sized planet in the habitable zone of a red dwarf—a star cooler than the sun—500...
Three years ago, Jennifer Francis of Rutgers University proposed that a warming Arctic was altering the behavior of the...
- 17 April 2014 12:48 pm , Vol. 344 , #6181
- About Us
Live Chat: Chronic Fatigue Syndrome—Science and Controversy
21 September 2011 3:36 pm
See below for the chat box. Join us each Thursday at 3 p.m. EST for a live conversation with leading scientists and expert reporters.
Two years ago, Science published a paper suggesting that a mouse retrovirus called XMRV might be involved in chronic fatigue syndrome (CFS), a debilitating disease with no known cause. The study raised worries that XMRV might be spreading via blood donations. Since then, many other studies have failed to find XMRV in CFS patients, and some have suggested that the 2009 paper was the result of lab contamination.
Where does the science stand today? And how has the long and sometimes bitter debate affected the scientific field and CFS patients? Join us for a live chat on this page at 3 p.m. EDT on Thursday, 22 September, to discuss these and other questions with Michael Busch, a transfusion medicine scientist involved in XMRV research, and retrovirologist Jay Levy. You can leave your questions in the comment box below before the chat starts.
Save to my calendar
Michael P. Busch
Michael P. Busch is director of the Blood Systems Research Institute in San Francisco, California. He has led many studies in transfusion medicine and is a member of the Blood XMRV Scientific Research Working Group, a government-funded panel investigating whether XMRV is a risk to the blood supply.
Jay Levy studies HIV/AIDS at the University of California, San Francisco. The main focus of his work is HIV pathogenesis. In July, he published a study in Science that failed to find XMRV in chronic fatigue syndrome patients.